OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: Ohio State University

9 Projects | 3 Researchers | $1,409,302 Invested

2016

Ohio State University

Chien-liang Lin, PhD

Development of small molecule activators of glutamate transporter EAAT2 translation for AD (Year Three- bridge funding)

  • Funding Amount: $176,156
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed

2016

Ohio State University

Sung Ok Yoon, PhD

Discovery and preclinical development of isoform selective JNK inhibitors for Alzheimer's disease

  • Funding Amount: $153,405
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Neuronal Degeneration
  • Status: Closed

2015

Ohio State University

Sung Ok Yoon, PhD

ADD ON: Testing novel JNK3-selective inhibitors in Alzheimer's disease mouse models

  • Funding Amount: $47,397
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Neuronal Degeneration
  • Status: Closed

2015

Ohio State University

Chien-liang Lin, PhD

Development of small molecule activators of glutamate transporter EAAT2 translation for AD (year two)

  • Funding Amount: $244,008
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed

2013

Ohio State University

Chien-liang Lin, PhD

Development of small molecule activators of glutamate transporter EAAT2 translation for Alzheimer's disease

  • Funding Amount: $220,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed

2013

Ohio State University

Sung Ok Yoon, PhD

Testing novel JNK3-selective inhibitors in Alzheimer's disease mouse models

  • Funding Amount: $158,336
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2012

Ohio State University

Jeff Kuret, PhD

Imaging agents for diagnosis of tauopathic neurodegenerative diseases

  • Funding Amount: $150,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Status: Closed

2011

Ohio State University

Jeff Kuret, PhD

Imaging agents for diagnosis of tauopathic neurodegenerative diseases

  • Funding Amount: $125,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2008

Ohio State University

Jeff Kuret, PhD

Contrast agents for premortem diagnosis and staging of Alzheimer's disease

  • Funding Amount: $135,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed